Carfilzomib for relapsed and refractory multiple myeloma

por Groen, K, van de Donk, NWCJ, Stege, CAM, Zweegman, S, Nijhof, IS
Publicado 2019

Evidence against the Human Metapneumovirus G, SH, and M2-2 Proteins as Bona Fide Interferon Antagonists

por Groen, K., van Nieuwkoop, S., Lamers, M. M., Fouchier, R. A. M., van den Hoogen, B. G.
Publicado 2022

P18 SKIN EXPRESSION OF P16(INK4A), A BIOMARKER FOR CELLULAR SENESCENCE, DOES NOT PREDICT FRAILTY OR TREATMENT OUTCOME IN NEWLY DIAGNOSED MULTIPLE MYELOMA

por Smits, F., Groen, K., Stege, C., Seefat, M., Nijhof, I., van de Donk, N., Ypma, P., Zweegman, S.
Publicado 2023

Bioavailability of inorganic arsenic from bog ore-containing soil in the dog.

por Groen, K, Vaessen, H A, Kliest, J J, de Boer, J L, van Ooik, T, Timmerman, A, Vlug, R F
Publicado 1994

An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown

por Kivit, CMHJ, Groen, K, Jongbloed, M, Linssen, CFM, van Loo, A, van Gorp, ECM, van Nieuwkoop, S, den Hoogen, BG van, Kruif, MD de
Publicado 2022

P53 REAL-WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH

por Seefat, M.R., Cucchi, D.G.J., Groen, K., Donker, M.L., van der Hem, K.G., Westerman, M., Gerrits, A.M., Beeker, A., van de Donk, N., Blommestein, H.M., Zweegman, S.
Publicado 2023

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P...

por Groen, K., Stege, C., Nasserinejad, K., de Heer, K., van Kampen, R., Leys, R., Thielen, N., Westerman, M., Wu, K., Ludwig, I., Issa, D., Velders, G., Vekemans, M., van de Donk, N., Timmers, G., de Boer, F., Tick, L., van der Spek, E., de Waal, E., Sohne, M., Sonneveld, P., Nijhof, I., Klein, S., Levin, M., Ypma, P., Zweegman, S.
Publicado 2023

P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESUL...

por Groen, K., Seefat, M. R., van der Holt, B., Schjesvold, F. H., Stege, C. A., Levin, M.-D., Hansson, M., Leys, R. B., Regelink, J., Waage, A., Szatkowski, D., Axelsson, P., Do, T. H., Svirskaite, A., van der Spek, E., Haukas, E., Knut-Bojanowska, D., Ypma, P. F., Blimark, C., Mellqvist, U.-H., van de Donk, N. W., Sonneveld, P., Klostergaard, A., Vangsted, A. J., Abdilgaard, N., Zweegman, S.
Publicado 2022

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14...

por Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J., Ludwig, I., Thielen, N., Durdu-Rayman, N., de Graauw, N. C., van de Donk, N. W., de Waal, E. G., Vekemans, M.-C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A., Silbermann, M. H., Oosterveld, M., Nijhof, I., Sonneveld, P., Klein, S. K., Levin, M.-D., Zweegman, S.
Publicado 2022

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

por Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.
Publicado 2023